Tioga Medical Campbekk, CAhttp://www.tiogahealth.org/ Key contact Name Title Mike Dineen President & CEO CAMPBELL, CA, Tioga Medical, a newly formed Shifamed portfolio company, announced today the closing of its Series A preferred stock financing, raising a total of $15M. Tioga Medical was founded to provide physicians and patients with an elegant transcatheter valve replacement experience […]
Archivio Categoria: venture capital funding
04
Apr
Apr
Teridion 300 Brannan Street, Suite 101San Francisco, CA 94107844-837-4346https://www.teridion.com/ Key contact Name Title Saar Gillai CEO SAN FRANCISCO, CA, Teridion today announced that it has closed $9 million in financing. Teridion, the company delivering the only public cloud-based WAN service backed by a carrier grade SLA, today announced that it has closed $9 million in […]
04
Apr
Apr
Inanovate 2329 North Career Ave, Suite 113Sioux Falls, SD 57107605-679-6460http://inanovate.com/ Key contact Name Title David Ure Founder & CEO SIOUX FALLS, S.D., Inanovate has secured an initial closing of $3.1 million on a Series C financing round. Inanovate, a life science company specializing in the development of blood tests for cancer and autoimmune diseases, has […]
03
Apr
Apr
Affirm PO Box 2854�San Francisco, CA 94126415-535-8050https://www.affirm.com Key contact Name Title Max Levchin CEO SAN FRANCISCO, CA, Financial technology company has raised a $300 million series F round of funding led by Thrive Capital. Affirm, the financial technology company founded by entrepreneur Max Levchin to provide honest financial products that improve lives, today announced it […]
03
Apr
Apr
Deepwatch 146 2nd Street North, Suite 107Saint Petersburg, FL 33701855-303-3033https://www.deepwatch.com/ Key contact Name Title Charlie Thomas CEO ST. PETERSBURG, FL, Leading provider of intelligence-driven managed security services, has closed a $23M Series A funding round led by ABS Capital Partners. deepwatch, a leading provider of intelligence-driven managed security services, announced the closing of a USD […]
03
Apr
Apr
Dyne Therapeutics 400 Technology Square, 10th FloorCambridge, MA 02139https://www.dyne-tx.com/ Key contact Name Title Romesh Subramanian CEO CAMBRIDGE, MA, New biotechnology company pioneering targeted therapies for patients with serious muscle diseases, launched today with a $50 million Series A. Dyne Therapeutics, a new biotechnology company pioneering targeted therapies for patients with serious muscle diseases, launched today […]
GIBLIB 3470 Wilshire Blvd.Los Angeles, CA 92866https://giblib.com/ Key contact Name Title Brian Conyer CEO LOS ANGELES, CA, Streaming media platform has closed $2,500,000 in seed funding. GIBLIB, the streaming media platform offering the largest library of on-demand medical lectures and surgical videos in 4K and 360-degree virtual reality, has closed $2,500,000 in seed funding. The […]
02
Apr
Apr
SpringWorks Therapeutics 100 Washington Blvd.Stamford, CT 06902203-883-9490https://www.springworkstx.com/ Key contact Name Title Saqib Islam CEO STAMFORD, CT, SpringWorks Therapeutics announced the closing of a $125 million Series B preferred stock financing led by Perceptive Advisors. SpringWorks Therapeutics, Inc. (the "Company"), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and […]
02
Apr
Apr
EzCater 101 Arch StreetBoston, MA 02108800-488-1803https://www.ezcater.com/ Key contact Name Title Stefania Mallett CEO BOSTON, MA, ezCater, the world's largest online catering marketplace, today announced that it has raised a $150 million Series D-1 investment round The round was co-led by Lightspeed Venture Partners and GIC. ezCater will use the funds to continue its global expansion […]
Aura Biosciences 85 Bolton StreetCambridge, MA 02140617-871-1241www.aurabiosciences.com Key contact Name Title Elisabet de los Pinos CEO CAMBRIDGE, MA, Aura Biosciences today announced that it closed a $40 million Series D financing. Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that it closed a $40 million Series D […]